Use of low titer O whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypass

Documenti analoghi

• Prevalence and clinical implications of heightened plastic chemical exposure in pediatric patients undergoing cardiopulmonary bypass
  di: Devon Guerrelli, et al.
  Pubblicazione: (2024)
• Survey of quality control testing practices on low titer group O whole blood in the United States
  di: Mark H. Yazer, et al.
  Pubblicazione: (2026)
• Survey of policies at US hospitals on the selection of RhD type of low‐titer O whole blood for use in trauma resuscitation
  di: Skye Clayton, et al.
  Pubblicazione: (2024)
• Low titer group O whole blood inventory conservation: The effect of implementing group A whole blood at a simulated civilian trauma center
  di: Emilie A. Jochumsen, et al.
  Pubblicazione: (2026)
• Expanding beyond trauma: Characterizing low titer group O whole blood (LTOWB) use in children requiring massive transfusion protocol activation
  di: Erin V. Feeney, et al.
  Pubblicazione: (2025)